Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 99
Filtrar
Más filtros

Medicinas Complementárias
Tipo del documento
Intervalo de año de publicación
1.
Toxins (Basel) ; 13(8)2021 07 21.
Artículo en Inglés | MEDLINE | ID: mdl-34437380

RESUMEN

The jellyfish species that inhabit the Mediterranean coastal waters are not lethal, but their stings can cause severe pain and systemic effects that pose a health risk to humans. Despite the frequent occurrence of jellyfish stings, currently no consensus exists among the scientific community regarding the most appropriate first-aid protocol. Over the years, several different rinse solutions have been proposed. Vinegar, or acetic acid, is one of the most established of these solutions, with efficacy data published. We investigated the effect of vinegar and seawater on the nematocyst discharge process in two species representative of the Mediterranean region: Pelagia noctiluca (Scyphozoa) and Carybdea marsupialis (Cubozoa), by means of (1) direct observation of nematocyst discharge on light microscopy (tentacle solution assay) and (2) quantification of hemolytic area (tentacle skin blood agarose assay). In both species, nematocyst discharge was not stimulated by seawater, which was classified as a neutral solution. In P. noctiluca, vinegar produced nematocyst discharge per se, but inhibited nematocyst discharge from C. marsupialis. These results suggest that the use of vinegar cannot be universally recommended. Whereas in case of a cubozoan C. marsupialis sting, the inhibitory effect of vinegar makes it the ideal rinse solution, in case of a scyphozoan P. noctiluca sting, vinegar application may be counterproductive, worsening the pain and discomfort of the stung area.


Asunto(s)
Ácido Acético/administración & dosificación , Mordeduras y Picaduras/tratamiento farmacológico , Cubomedusas , Primeros Auxilios/métodos , Escifozoos , Animales , Hemólisis/efectos de los fármacos , Intestino Delgado , Nematocisto/efectos de los fármacos , Agua de Mar , Especificidad de la Especie , Porcinos
2.
Acta Biochim Pol ; 68(2): 287-292, 2021 May 11.
Artículo en Inglés | MEDLINE | ID: mdl-33974793

RESUMEN

The current research aimed to evaluate the effects of dietary inclusion of wood vinegar on growth performance, nutrient digestibility, and meat quality of grower-finisher pigs. In total, 132 crossbred ({Landrace × Yorkshire × Duroc}) grower-finisher pigs with an initial average body weight 30.48±4.23 kg (11 replications/treatment; 4 pigs/pen) were used in a 16-week trial. Based on the body weight and sex the pigs were randomly assigned to three treatments. Dietary treatments consisted of the basal diet (CON) or the basal diet supplemented with 0.05% and 0.1% wood vinegar. The inclusion of dietary wood vinegar supplementation significantly improved the body weight gain (BWG) and average daily gain (ADG) (P=0.0521; 0.043) of pigs at week 16. The total track nutrient digestibility of dry matter and nitrogen was linearly increased in pigs fed with an increased amount of wood vinegar. In addition, dietary supplementation of wood vinegar linearly improved longissimus muscle area, yellowness (b*) of the meat color, and carcass weight (P<0.05) and a tendency in linear reduction was observed for water holding capacity (P=0.068), and drip loss at d5 and d7 (P=0.091, 0.069). However, there was no significant difference found for lean meat percentage and backfat thickness in this experiment. In summary, dietary inclusion of wood vinegar supplementation enhanced growth performance and total track digestibility of nutrients and had no effects on lean meat percentage and backfat thickness of grower-finisher pigs.


Asunto(s)
Alimentación Animal/análisis , Digestión , Carne/análisis , Porcinos/crecimiento & desarrollo , Terpenos/administración & dosificación , Ácido Acético/administración & dosificación , Tejido Adiposo/crecimiento & desarrollo , Animales , Dieta/métodos , Suplementos Dietéticos , Femenino , Masculino , Nutrientes , Aumento de Peso
3.
Int J Cancer ; 149(2): 371-377, 2021 07 15.
Artículo en Inglés | MEDLINE | ID: mdl-33687746

RESUMEN

Malawi has the highest invasive cervical cancer (ICC) mortality rate worldwide, and ICC is the leading cause of cancer death among women. In 2004, Malawi adopted visual inspection with acetic acid (VIA) and ablative treatment with cryotherapy. However, screening coverage has remained low (<30%) and few women (<50%) who require ablative treatment receive it. Additional barriers include long distances to health facilities and challenges with maintaining gas supplies. Thermal ablation is a safe and effective alternative to cryotherapy. We assessed the safety and uptake of community-based ICC screening with VIA and same-day treatment using a handheld thermocoagulator (HTU) in rural Malawi. We held educational talks alongside community leaders and conducted VIA screening in nonclinic community settings to nonpregnant women aged 25 to 49 years without history of hysterectomy or genital cancer/precancer. Eligible women received same-day thermal ablation and HIV testing/counseling. We collected cervical biopsies before treatment and followed up women at Weeks 6 and 12, with repeat biopsy at Week 12. Between July and August 2017, 408 (88%) of 463 eligible women underwent VIA. Overall, 7% (n = 30) of women had a positive VIA, of whom 93% (n = 28) underwent same-day thermal ablation. Among the 30 VIA-positive women, 5 had cervical intraepithelial neoplasia (CIN) 1, 4 had CIN 2/3 and 21 had benign histologic findings. Abnormal vaginal discharge (60%) and light vaginal bleeding (52%) were the most reported adverse events. There was high uptake of the community-based ICC screening in the study population and treatment was safe in this setting. Similar strategies that minimize false-positive results are urgently needed in Malawi.


Asunto(s)
Ácido Acético/administración & dosificación , Hipertermia Inducida/métodos , Displasia del Cuello del Útero/terapia , Neoplasias del Cuello Uterino/terapia , Adulto , Detección Precoz del Cáncer , Femenino , Humanos , Hipertermia Inducida/efectos adversos , Malaui , Tamizaje Masivo , Persona de Mediana Edad , Población Rural
4.
Trop Anim Health Prod ; 53(1): 83, 2021 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-33411117

RESUMEN

This experiment examines the effects of bamboo charcoal (BC) powder, bamboo vinegar (BV), and their combination (BCV) in the diet of laying hens on performance, egg quality, relative organ weights, and intestinal bacterial populations. A total of 320 laying hens (36 weeks of age) were divided into 4 treatment groups, with 10 replicates per treatment and 8 hens per replicate. They were fed on a control diet, the control diet supplemented with 0.8% BC, the control diet supplemented with 0.4% BV, or the control diet supplemented with a combination of BC (0.8%) and BV (0.4%) from 36 to 51 weeks of age. Egg production increased in the hens fed the BV and BCV diets during 48 to 51 weeks of age (P < 0.05). Damaged egg rate decreased in the hens fed the BV and BCV diets for the whole experiment (P < 0.05). Shell thickness was highest in the BCV-fed group at week 43, and shell strength was higher in the BV-fed group at week 51 (P < 0.05). Supplementation of BC or BCV in the diet resulted in a decreased abdominal fat pad (P < 0.05). In the ileal content, the population of Salmonella spp. decreased in the BV and BCV groups and the population of Lactobacillus spp. increased in the BV group (P < 0.05). The present results indicate that feeding BV or BCV alleviates damaged egg rate and decreases intestinal pathogenic bacteria, while feeding BC benefits by reducing abdominal fat. These results suggest that the effect of BCV seems to be induced by the synergistic effect of BC and BV, and that the BCV contributes to the effective use of bamboo on the laying hen's production.


Asunto(s)
Ácido Acético/metabolismo , Carbón Orgánico/metabolismo , Pollos/fisiología , Microbioma Gastrointestinal/efectos de los fármacos , Tamaño de los Órganos/efectos de los fármacos , Óvulo/efectos de los fármacos , Poaceae/química , Ácido Acético/administración & dosificación , Alimentación Animal/análisis , Animales , Bacterias/efectos de los fármacos , Carbón Orgánico/administración & dosificación , Dieta/veterinaria , Suplementos Dietéticos/análisis , Femenino , Polvos/administración & dosificación , Polvos/metabolismo , Distribución Aleatoria
5.
J Acad Nutr Diet ; 121(5): 895-914, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33436350

RESUMEN

BACKGROUND: Acetic acid is a short-chain fatty acid that has demonstrated biomedical potential as a dietary therapeutic agent for the management of chronic and metabolic illness comorbidities. In human beings, its consumption may improve glucose regulation and insulin sensitivity in individuals with cardiometabolic conditions and type 2 diabetes mellitus. Published clinical trial evidence evaluating its sustained supplementation effects on metabolic outcomes is inconsistent. OBJECTIVE: This systematic review and meta-analysis summarized available evidence on potential therapeutic effects of dietary acetic acid supplementation via consumption of acetic acid-rich beverages and food sources on metabolic and anthropometric outcomes. METHODS: A systematic search was conducted in Medline, Scopus, EMBASE, CINAHL Plus, and Web of Science from database inception until October 2020. Randomized controlled trials conducted in adults evaluating the effect of dietary acetic acid supplementation for a minimum of 1 week were included. Meta-analyses were performed using a random-effects model on fasting blood glucose (FBG), triacylglycerol (TAG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), glycated hemoglobin (HbA1c), body mass index (BMI), and body fat percentage. Statistical heterogeneity was assessed by calculation of Q and I2 statistics, and publication bias was assessed by calculation of Egger's regression asymmetry and Begg's test. RESULTS: Sixteen studies were included, involving 910 participants who consumed between 750 and 3600 mg acetic acid daily in interventions lasting an average of 8 weeks. Dietary acetic acid supplementation resulted in significant reductions in TAG concentrations in overweight and obese but otherwise healthy individuals (mean difference [MD] = -20.51 mg/dL [95% confidence intervals = -32.98, -8.04], P = .001) and people with type 2 diabetes (MD = -7.37 mg/dL [-10.15, -4.59], P < .001). Additionally, acetic acid supplementation significantly reduced FBG levels (MD = -35.73 mg/dL [-63.79, -7.67], P = .01) in subjects with type 2 diabetes compared with placebo and low-dose comparators. No other changes were seen for other metabolic or anthropometric outcomes assessed. Five of the 16 studies did not specify the dose of acetic acid delivered, and no studies measured blood acetate concentrations. Only one study controlled for background acetic acid-rich food consumption during intervention periods. Most studies had an unclear or high risk of bias. CONCLUSION: Supplementation with dietary acetic acid is well tolerated, has no adverse side effects, and has clinical potential to reduce plasma TAG and FBG concentrations in individuals with type 2 diabetes, and to reduce TAG levels in people who are overweight or obese. No significant effects of dietary acetic acid consumption were seen on HbA1c, HDL, or anthropometric markers. High-quality, longer-term studies in larger cohorts are required to confirm whether dietary acetic acid can act as an adjuvant therapeutic agent in metabolic comorbidities management.


Asunto(s)
Ácido Acético/administración & dosificación , Glucemia/efectos de los fármacos , Índice de Masa Corporal , Suplementos Dietéticos , Lípidos/sangre , Adulto , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/terapia , Femenino , Hemoglobina Glucada/efectos de los fármacos , Humanos , Masculino , Obesidad/sangre , Obesidad/terapia , Sobrepeso/sangre , Sobrepeso/terapia
6.
Vet Med Sci ; 7(3): 766-772, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33326702

RESUMEN

The purpose of this research was to evaluate the effects of apple cider vinegar in diet on the growth performance, immune response, histomorphological changes of the small intestine and some serum biochemical factors in broilers. A total of 85 broiler chicks of Ross 308 were purchased and 64 well-conditioned chicks were selected and divided into four experimental groups with four replicates and four chicks per replicate. The diets of groups 2, 3 and 4 were mixed with 1, 2 and 3% of vinegar, respectively, and group 1 as the control group was fed by the standard diet. The results showed that body weight gain was higher in the groups fed vinegar than the control group. There were no significant changes in the feed conversion ratio between the treatment and control groups (p = .507). Vinegar intake through the diet did not change significantly the weight of Bursa of Fabricius (p = .369) and spleen (p = .122). Vinegar significantly reduced blood urea nitrogen levels in the treatment groups compared with the control group (p = .0052). There was a significant increase in the level of antibody titre against Newcastle disease virus by haemagglutination inhibition test in the groups receiving vinegar in comparison with control group (p = .0358). Compared with the control group, the villus height (p = .0022) and intestinal crypts depth (p = .0015) significantly increased in the groups receiving apple cider vinegar. In conclusion, dietary supplementation with apple cider vinegar has beneficial effects on performance, immune response and small intestine histomorphology in broilers.


Asunto(s)
Ácido Acético/metabolismo , Pollos/fisiología , Inmunidad/efectos de los fármacos , Intestino Delgado/efectos de los fármacos , Ácido Acético/administración & dosificación , Alimentación Animal/análisis , Animales , Pollos/anatomía & histología , Pollos/crecimiento & desarrollo , Pollos/inmunología , Dieta/veterinaria , Suplementos Dietéticos/análisis , Relación Dosis-Respuesta a Droga , Intestino Delgado/anatomía & histología , Distribución Aleatoria
7.
Curr Drug Discov Technol ; 18(4): 525-531, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-32357814

RESUMEN

INTRODUCTION: The present study deals with the effect of Nectaroscordum koelzi fruit extract on acute and chronic inflammation. METHODS: A total of 84 NMRI mice were used in this study. The effect of the extract on acute inflammation was analyzed by increasing vascular permeability via acetic acid and xylene induced ear edema among mice. The extract was evaluated in terms of effects on chronic inflammation by means of the cotton pellet test among mice. For the assessment of inflammation degree, the mice paw edema volume was measured by the plethysmometric test. RESULTS: The findings showed that the extract was effective on acute inflammation induced by acetic acid in mice. In the xylene ear edema, N. koelzi extract indicated a significant activity in mice. In the cotton pellet method, the methanol extract produced a significant reduction in comparison with the control and dexamethasone. Mice paw edema volume decreased with the extract. CONCLUSION: In general, the data from the experiments indicated that the methanol extract of N. koelzi has an anti-inflammatory effect on acute and chronic inflammation. However, the exact contributing mechanisms have not been investigated for the pharmacological effects.


Asunto(s)
Allium/química , Antiinflamatorios/farmacología , Edema/tratamiento farmacológico , Inflamación/tratamiento farmacológico , Extractos Vegetales/farmacología , Ácido Acético/administración & dosificación , Ácido Acético/toxicidad , Animales , Antiinflamatorios/aislamiento & purificación , Antiinflamatorios/uso terapéutico , Permeabilidad Capilar/efectos de los fármacos , Permeabilidad Capilar/inmunología , Modelos Animales de Enfermedad , Oído/irrigación sanguínea , Edema/inducido químicamente , Edema/inmunología , Edema/patología , Humanos , Inflamación/inmunología , Masculino , Metanol/química , Ratones , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/uso terapéutico , Xilenos/administración & dosificación , Xilenos/toxicidad
8.
Sci Rep ; 10(1): 21102, 2020 12 03.
Artículo en Inglés | MEDLINE | ID: mdl-33273564

RESUMEN

Previous studies have suggested that vinegar intake can help to reduce body fat and hyperglycemia. Therefore, this study aimed to evaluate the anti-obesity efficacy of vinegar fermented using Cudrania tricuspidata fruits (CTFV) and its main phenolic constituents and to analyze its molecular mechanism and changes in obesity-related metabolizing enzymatic activities. We found that HFD significantly caused hepatic steatosis; increases in body fats, feed efficiency, liver mass, lipids, insulin, oxidative parameters, cardiovascular-associated risk indices, lipase and α-amylase activities, whereas CTFV efficaciously attenuated HFD-induced oxidant stress, fat accumulation, obesity-related enzymatic activity, and the activation or reduction of obesity-related molecular reactions via improving metabolic parameters including phosphorylated insulin receptor substrate 1, protein tyrosine phosphatase 1B, phosphorylated phosphoinositide 3-kinase/protein kinase B, phosphorylated mitogen-activated protein kinases, sterol regulatory element-binding protein 1c, CCAAT/enhancer-binding protein, and fatty acid synthase; and decreases in adiponectin receptor 1, leptin receptor, adenosine monophosphate-activated protein kinase, acetyl-CoA carboxylase, and peroxisome proliferator-activated receptor, subsequently ameliorating HFD-induced obesity. Therefore, CTFV might provide a functional food resource or nutraceutical product for reducing body fat accumulation.


Asunto(s)
Ácido Acético/administración & dosificación , Ácido Acético/uso terapéutico , Dieta Alta en Grasa , Frutas/química , Metabolismo de los Lípidos , Moraceae/química , Obesidad/tratamiento farmacológico , Ácido Acético/farmacología , Animales , Biomarcadores/sangre , Línea Celular , Supervivencia Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Fenofibrato/farmacología , Humanos , Metabolismo de los Lípidos/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/metabolismo , Ratones Obesos , Obesidad/sangre , Tamaño de los Órganos/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Fosforilación/efectos de los fármacos , Polifenoles/farmacología , Granada (Fruta)/química , Transducción de Señal/efectos de los fármacos , Aumento de Peso/efectos de los fármacos
9.
Nutrients ; 12(9)2020 Aug 19.
Artículo en Inglés | MEDLINE | ID: mdl-32825073

RESUMEN

Obesity is a worldwide epidemic characterized by excessive fat accumulation, associated with multiple comorbidities and complications. Emerging evidence points to gut microbiome as a driving force in the pathogenesis of obesity. Vinegar intake, a traditional remedy source of exogenous acetate, has been shown to improve glycemic control and to have anti-obesity effects. New functional foods may be developed by supplementing traditional food with probiotics. B. coagulans is a suitable choice because of its resistance to high temperatures. To analyze the possible synergic effect of Vinegar and B. coagulans against the metabolic alterations induced by a high fat diet (HFD), we fed twelve-week-old C57BL/6 mice with HFD for 5 weeks after 2 weeks of acclimation on a normal diet. Then, food intake, body weight, blood biochemical parameters, histology and liver inflammatory markers were analyzed. Although vinegar drink, either alone or supplemented with B. coagulans, reduced food intake, attenuated body weight gain and enhanced glucose tolerance, only the supplemented drink improved the lipid serum profile and prevented hepatic HFD-induced overexpression of CD36, IL-1ß, IL-6, LXR and SREBP, thus reducing lipid deposition in the liver. The beneficial properties of the B. coagulans-supplemented vinegar appear to be mediated by a reduction in insulin and leptin circulating levels.


Asunto(s)
Ácido Acético/administración & dosificación , Ácido Acético/farmacología , Bacillus coagulans , Dieta Alta en Grasa/efectos adversos , Suplementos Dietéticos , Hígado Graso/dietoterapia , Hígado Graso/etiología , Alimentos Funcionales , Resistencia a la Insulina , Hígado/metabolismo , Malus , Obesidad/dietoterapia , Obesidad/etiología , Probióticos/administración & dosificación , Probióticos/farmacología , Aumento de Peso/efectos de los fármacos , Animales , Fármacos Antiobesidad , Ingestión de Alimentos/efectos de los fármacos , Hígado Graso/prevención & control , Microbioma Gastrointestinal , Metabolismo de los Lípidos/efectos de los fármacos , Masculino , Ratones Endogámicos C57BL , Obesidad/metabolismo , Obesidad/microbiología
10.
Drug Res (Stuttg) ; 70(11): 493-502, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32707592

RESUMEN

An efficient and environmental benign solvent-free synthesis of 5-amino-3-aryl-1-(6'-chloropyridazin-3'-yl)pyrazoles (4A-E): was accomplished by grinding 3-chloro-6-hydrazinopyridazine (2): and ß-ketonitriles (3A-E): in the presence of p-toulenesulfonic acid as a catalyst. Subsequently, 6'-chloro group in 4A-E: was replaced with cyclic 2° amine derivatives viz. pyrrolidine 5A: , piperidine 5B: and morpholine 5C: to obtain 6A-E: , 7A-E: , 8A-E: respectively. The newly synthesized compounds were characterized by using IR, NMR (1H and 13C), mass spectral studies, elemental analyses. All the synthesized compounds were studied for their docking interaction with target protein 6COX and screened for their in vivo analgesic mode of action against swiss albino mice (animal model) using acetic-acid induced writhing test. Consequently, docking simulations data justifies the potential of synthesized series as an analgesic and very well correlated with in vivo study. Preliminary results revealed that most of the synthesized compounds exhibited moderate to good analgesic activity as compared to reference/standard drug (s) sodium diclofenac and candidates 4D: and 7C: protrude out as a promising lead for further investigation.


Asunto(s)
Inhibidores de la Ciclooxigenasa 2/farmacología , Diseño de Fármacos , Dolor/tratamiento farmacológico , Pirazoles/farmacología , Piridazinas/farmacología , Ácido Acético/administración & dosificación , Ácido Acético/toxicidad , Animales , Ciclooxigenasa 2/metabolismo , Ciclooxigenasa 2/ultraestructura , Inhibidores de la Ciclooxigenasa 2/síntesis química , Inhibidores de la Ciclooxigenasa 2/uso terapéutico , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Humanos , Ratones , Simulación del Acoplamiento Molecular , Dolor/inducido químicamente , Pirazoles/química , Pirazoles/uso terapéutico , Piridazinas/química , Piridazinas/uso terapéutico , Relación Estructura-Actividad
11.
Poult Sci ; 99(4): 2266-2274, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-32241512

RESUMEN

A 2 × 6 factorial experiment was conducted to evaluate the effect of Satureja khuzistanica essential oils (SkEO; 0, 200, 300, 400, 500, and 600 mg/bird/day) administered via oral gavage and dietary acetic acid (AA; 0 and 20 g/1 kg) on fatty acids (FA) composition in thigh meat of Ross 308 broiler chickens at days 34, 38, and 42 of age. Dietary AA reduced DWG, DFI, and European economic efficiency index, and increased FCR compared with the nonacidified diet. In day 34 of age, saturated FA (SFA) percentage reduced and polyunsaturated FA (PUFA), n-3, and n-6 percentages increased in the birds that received 400 mg SkEO. Mean monounsaturated FA (MUFA) percentage was greater, whereas PUFA, n-3, n-6, and total FA (TFA) percentages were lesser in the birds fed on the acidified diet. In day 38 of age, mean PUFA, TFA, n-3, and n-6 percentages were greater while MUFA and cis FA (CFA) concentrations were lesser in the thigh muscle of the birds that received 400 mg SkEO. Mean MUFA, PUFA, n-3, n-6, CFA, and TFA percentages were lower in the birds maintained on the acidified diet. In day 42 of age, mean SFA percentage reduced in the birds given 300 mg SkEO, while TFA percentage lowered in the birds that received 200 and 600 mg SkEO. The acidified diet decreased MUFA, TFA, and CFA percentage and increased SFA and the n-6 to n-3 fatty acids ratio of thigh meat in chicken. The results led to the conclusion that the daily enteral administration of SkEO through oral gavage may feasibly modify the fatty acids profile of thigh meat in favor of increased PUFA. Dietary AA and its interaction with SkEO inconsistently modified concentration of certain classes of fatty acids in broiler thigh meat, particularly in advanced ages. Almost all alterations induced by AA-involving treatments in fatty acids composition of thigh meat were on the contrary to the SkEO influences as they were in favor of an increased SFA proportion.


Asunto(s)
Ácido Acético/metabolismo , Pollos/fisiología , Ácidos Grasos/análisis , Carne/análisis , Aceites Volátiles/metabolismo , Satureja/química , Ácido Acético/administración & dosificación , Alimentación Animal/análisis , Animales , Dieta/veterinaria , Suplementos Dietéticos/análisis , Relación Dosis-Respuesta a Droga , Masculino , Aceites Volátiles/administración & dosificación , Distribución Aleatoria , Muslo
12.
J Sci Food Agric ; 100(6): 2380-2388, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31901136

RESUMEN

BACKGROUND: An imbalanced fat or excess energy intake always results in obesity and increased serum/liver lipids, thus leading to metabolic syndromes. Given the bioactive components in black vinegar (BV), such as branched amino acids, phenolic profile, and mineral contents, we investigated the antiobesity effects of BV-based supplements in rats fed a high-fat diet (HFD). RESULTS: HFD (30% fat, w/w) feeding increased (P < 0.05) body weight, weight gains, weights of livers and mesenteric, epididymal, and perirenal adipose tissues, and serum/liver triglyceride levels relative to those of rats fed a normal diet (4% fat, w/w; CON). These increased values were ameliorated (P < 0.05) by supplementing with BV-based supplements but were still higher (P < 0.05) than those of CON rats. The increased areas of perirenal adipocytes in rats fed with an HFD were also decreased (P < 0.05) by supplementing with BV-based supplements, which might result from an upregulation (P < 0.05) of 5'-adenosine monophosphate-activated protein kinase (AMPK), carnitine palmitoyltransferase-1 (CPT1), and uncoupling protein-2 (UCP2) in the perirenal adipose tissues. A similar effect was observed for AMPK, peroxisome proliferator-activated receptor alpha, retinoid X receptor alpha, CPT1, and UCP2 gene and protein levels in livers (P < 0.05). Generally, BV-based supplements increased the fecal triglyceride, cholesterol, and bile acid levels of rats fed with an HFD, which partially contribute to the lipid-lowering effects. Furthermore, BV-based supplements increased (P < 0.05) hepatic Trolox equivalent antioxidant capacity and lowered (P < 0.05) serum/liver thiobarbituric acid reactive substances values in HFD-fed rats. CONCLUSION: In a chronic high-fat dietary habit, the food-grade BV-based supplement is a good daily choice to ameliorate obesity and its associated comorbidities. © 2020 Society of Chemical Industry.


Asunto(s)
Ácido Acético/administración & dosificación , Ácido Acético/metabolismo , Fármacos Antiobesidad/farmacología , Metabolismo de los Lípidos/efectos de los fármacos , Adipocitos , Animales , Antioxidantes , Dieta Alta en Grasa/efectos adversos , Suplementos Dietéticos , Metabolismo Energético , Heces/química , Masculino , Ratas Wistar
13.
Appetite ; 144: 104460, 2020 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-31536745

RESUMEN

Oral responsiveness to the burning/spicy sensation affects food behaviors and diet; therefore, it is reasonable to hypothesize that the variation in nasal responsiveness to irritant foods may play a role in modulating food behaviors. This study explored the variation among individuals in orthonasal irritation induced by smelling food ingredients containing irritant compounds: mustard oil (2.0, 10.0, and 100.0% v/v mustard oil in corn oil; irritant compound: allyl isothiocyanate); vinegar (3.5, 42.3, and 98.6% v/v vinegar in water; irritant compound: acetic acid); and wasabi (0.1, 0.2, and 0.4% w/w wasabi powder in water; irritant compound: allyl isothiocyanate). Sixty-eight subjects (40% males; 19-87 years) smelled the nine samples and rated their perceived intensity of odor, irritation and liking. Wide individual variation in the perception of irritation and odor intensity was found, especially at the highest concentrations. Young individuals were the most sensitive to all stimuli. No significant differences were found between males and females. Fifty-seven percent of subjects were "HYPO" and 43 percent "HYPER" responsive to irritation, respectively. Perceived irritation was positively correlated with odor intensity and tended to be negatively correlated with liking, especially in familiar stimuli. The results suggest that the variation in nasal responsiveness to irritant foods may contribute to influencing food acceptance and therefore, to modulating food behaviors.


Asunto(s)
Preferencias Alimentarias/efectos de los fármacos , Individualidad , Irritantes/administración & dosificación , Odorantes/análisis , Percepción Olfatoria/efectos de los fármacos , Ácido Acético/administración & dosificación , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Isotiocianatos/administración & dosificación , Masculino , Persona de Mediana Edad , Planta de la Mostaza , Estimulación Física , Aceites de Plantas/administración & dosificación , Polvos/administración & dosificación , Umbral Sensorial/efectos de los fármacos , Olfato/efectos de los fármacos , Wasabia/química , Adulto Joven
14.
Clin Nutr ESPEN ; 32: 1-7, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-31221273

RESUMEN

Vinegar intake is considered a food item that improves blood glucose in humans. This review aimed to discuss studies that investigated the impact of vinegar intake on the glycemic profile in humans and the putative mechanistic cellular pathways in both human and animal models. A search of literature was performed on the Cochrane, MEDLINE and Web of Science databases for articles published between 1995 and 2018. There is considerable support for vinegar having a positive acute effect on blood glucose levels when combined with carbohydrate-rich meals. Conversely, there are few chronic interventions analyzing the impact of vinegar intake on blood glucose. Based on available evidence, we hypothesize three pathways by which vinegar may improve blood glucose: The inhibition of α-amylase action; increased glucose uptake; and mediation by transcription factors. When evaluating the current body of literature, daily vinegar intake in amounts of ∼10-30 mL (∼2-6 tablespoons) appear to improve the glycemic response to carbohydrate-rich meals; however, there is a paucity of studies investigating chronic effects of vinegar intake.


Asunto(s)
Ácido Acético/farmacología , Glucemia/efectos de los fármacos , Diabetes Mellitus Tipo 2 , Ácido Acético/administración & dosificación , Glucemia/metabolismo , Suplementos Dietéticos , Humanos , Fenómenos Fisiológicos de la Nutrición , Periodo Posprandial
15.
Fish Shellfish Immunol ; 86: 900-905, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30553888

RESUMEN

This experiment was conducted to evaluate the effects of dietary supplementation of Apple cider vinegar (ACV) and propionic acid (PA) on biochemical parameters of hemolymph, intestinal microbiota and histology of hepatopancreas in white shrimp (Litopenaeus vannamei). Five experimental diets were evaluated in this study including diets supplemented with 1.0, 2.0 and 4.0% of ACV, 0.5% propionic acid, and a control diet with no supplements. Shrimps (initial weight of 10.2 ±â€¯0.04 g) in triplicate groups with the density of 25 shrimps per tank were fed the diets for 60 days. At the end of the feeding trial, shrimps fed with ACV and PA supplemented diets had significantly higher total protein level than those fed the control diet (P < 0.05). The number of Vibrio spp., R-cells (lipid storage cells) of hepatopancreas and cholesterol level in shrimps fed the diets containing ACV and PA were lower compared to the control group (P < 0.05). However, there was no remarkable variations in glucose concentration, B-cell number and tubule diameter among the experimental diets (P > 0.05). In addition, shrimps fed the ACV diets had significantly lower total heterotrophic marine bacteria compared to the control or PA groups, and the lowest bacterial number was observed in shrimp fed 4% ACV supplemented diet (P < 0.05). Supplementation of 2 and 4% ACV as well as 0.5% PA in the diet led to a significantly higher calcium concentration than the control treatment (P < 0.05). The lowest triglyceride concentration was observed in the shrimps fed diets containing 2.0 and 4.0% ACV, which resulted in 15 and 20% reduction, respectively (P < 0.05). Overall, the findings indicates that ACV and PA possess antimicrobial activity and demonstrate beneficial effects on health status, so they can be potentially used as feed additive in the feeding of L. vannamei.


Asunto(s)
Ácido Acético/metabolismo , Microbioma Gastrointestinal/efectos de los fármacos , Hemolinfa/efectos de los fármacos , Hepatopáncreas/efectos de los fármacos , Inmunidad Innata/efectos de los fármacos , Malus/química , Penaeidae/efectos de los fármacos , Propionatos/metabolismo , Ácido Acético/administración & dosificación , Alimentación Animal/análisis , Animales , Dieta , Suplementos Dietéticos/análisis , Hemolinfa/química , Hemolinfa/inmunología , Hepatopáncreas/anatomía & histología , Penaeidae/anatomía & histología , Penaeidae/inmunología , Propionatos/administración & dosificación , Distribución Aleatoria , Vibrio/fisiología
16.
Pharmacol Res Perspect ; 6(6): e00438, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30455959

RESUMEN

ω3-polyunsaturated free fatty acids (ω3-PUFAs), particularly docosahexaenoic (DHA) and eicosapentaenoic acid (EPA), are thought to exert health promoting effects in metabolic and in inflammatory diseases. The molecular mechanisms of these beneficial effects are only partially understood. DHA and EPA activate Free Fatty Acid receptor 4 (GPR120/FFA4). Recently, the first orally available, synthetic ligand of FFA4, 3-[2-chloro-5-(trifluoromethoxy)phenyl]-3-azaspiro[5.5]undecane-9-acetic acid ("compound A"; cpd A) has been developed. Cpd A exhibits distinctly higher potency, efficiency, and selectivity at FFA4 than ω3-PUFAs and ameliorates insulin resistance and adipose tissue inflammation in the mouse. With GPR120/FFA4 activation believed to also attenuate tissue inflammation in autoimmune diseases, cpd A may also have a beneficial effect in these diseases. We have therefore addressed the therapeutic potential of cpd A in mouse models of three prototypical autoimmune diseases, specifically psoriasis, rheumatoid arthritis, and bullous pemphigoid. The effect of cpd A on the course of Aldara™-induced psoriasis-like dermatitis, K/BxN serum transfer arthritis, and antibody transfer pemphigoid disease-like dermatitis was scrutinized. Cpd A did not alter the course of Aldara-induced psoriasis-like dermatitis, K/BxN serum transfer arthritis, or antibody transfer pemphigoid disease-like dermatitis. Our results suggest that therapeutic regimens solely relying on FFA4 activation do not bear the potential to treat inflammatory diseases. With cpd A distinctly more potent in activating GPR120/FFA4 than ω3-PUFAs, this also suggests that GPR120/FFA4 activation by ω3-PUFAs does not significantly contribute to the health-promoting effects of ω3-PUFAs in autoimmune diseases.


Asunto(s)
Ácido Acético/administración & dosificación , Antiinflamatorios no Esteroideos/administración & dosificación , Artritis Reumatoide/tratamiento farmacológico , Compuestos Aza/administración & dosificación , Penfigoide Ampolloso/tratamiento farmacológico , Psoriasis/tratamiento farmacológico , Receptores Acoplados a Proteínas G/agonistas , Ácido Acético/uso terapéutico , Administración Oral , Animales , Antiinflamatorios no Esteroideos/uso terapéutico , Artritis Reumatoide/inmunología , Compuestos Aza/uso terapéutico , Modelos Animales de Enfermedad , Ácidos Grasos Omega-3/metabolismo , Humanos , Imiquimod/inmunología , Ratones , Ratones Endogámicos C57BL , Penfigoide Ampolloso/inmunología , Psoriasis/inmunología , Receptores Acoplados a Proteínas G/inmunología , Receptores Acoplados a Proteínas G/metabolismo , Resultado del Tratamiento
17.
Can J Microbiol ; 64(10): 732-743, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-29775545

RESUMEN

This study investigated the use for bamboo vinegar powder as an antibiotic alternative in the diet of growing-finishing pigs by examining their digestive bacterial communities. Forty-five Duroc × Landrace × Yorkshire growing-finishing pigs were randomly allocated to five diet groups: 0%, 0.5%, 1.0%, or 1.5% bamboo vinegar levels and antibiotics. After 37 days, the digesta in duodenum of four pigs from each treatment were analyzed for their bacterial community compositions using 16S rRNA gene sequencing. The addition of 1.5% bamboo vinegar powder had an effect on the intestinal microflora most similar to that of antibiotics, indicating its potential to promote the growth and development of finishing pigs. We also found the 1.5% bamboo vinegar powder group to have an increased abundance of Firmicutes/Bacteroidetes compared with the other bamboo vinegar powder groups, which may enhance the ability of the host to absorb food energy and store more body fat. Additionally, the effects of bamboo vinegar powder on promoting the abundances of Lactobacillus and Thalassospira and on inhibiting Streptococcus and Prevotella growth revealed it may play an important role in animal production. Moreover, functional predictions of microbes via PICRUSt indicated that feed supplemented with 1.5% bamboo vinegar powder could promote many vital metabolic pathways.


Asunto(s)
Ácido Acético/administración & dosificación , Alimentación Animal , Bacterias/aislamiento & purificación , Aditivos Alimentarios , Extractos Vegetales/administración & dosificación , Sasa , Alimentación Animal/análisis , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Antibacterianos/administración & dosificación , Suplementos Dietéticos , Porcinos
18.
PLoS One ; 13(5): e0196867, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29723298

RESUMEN

Short chain fatty acids (SCFAs) are the main products of indigestible carbohydrates that are fermented by microbiota in the hindgut. This study was designed to investigate the effects of oral SCFAs administration on the lipid metabolism of weaned pigs. A total of 21 barrows were randomly allocated into three groups, including control group (orally infused with 200 mL physiological saline per day), low dose SCFAs group (orally infused with 200 mL SCFAs containing acetic acid 20.04 mM, propionic acid 7.71 mM and butyric acid 4.89 mM per day), and high dose SCFAs group (orally infused with 200 mL SCFAs containing acetic acid 40.08 mM, propionic acid 15.42 mM and butyric acid 9.78 mM per day). The results showed that the average daily feed intake of SCFAs groups were lower than that of control group (P<0.05). Oral administration of SCFAs decreased the concentrations of triglyceride (TG), total cholesterol (TC), high density lipoprotein-cholesterol and insulin (P<0.05), and increased the leptin concentration in serum (P<0.05). The total fat, as well as TC and TG levels in liver, was decreased by oral SCFAs administration (P<0.05). In addition, SCFAs down-regulated the mRNA expressions of fatty acid synthase (FAS) and sterol regulatory element binding protein 1c (P<0.05), and enhanced the mRNA expression of carnitine palmitoyltransferase-1α (CPT-1α) in liver (P<0.05). SCFAs also decreased FAS, acetyl-CoA carboxylase (ACC) and peroxisome proliferator activated receptor σ mRNA expressions in longissimus dorsi (P<0.05). And in abdominal fat, SCFAs reduced FAS and ACC mRNA expressions (P<0.05), and increased CPT-1α mRNA expression (P<0.05). These results suggested that oral administration of SCFAs could attenuate fat deposition in weaned pigs via reducing lipogenesis and enhancing lipolysis of different tissues.


Asunto(s)
Ácido Acético/administración & dosificación , Tejido Adiposo/efectos de los fármacos , Ácido Butírico/administración & dosificación , Regulación de la Expresión Génica/efectos de los fármacos , Lipogénesis/efectos de los fármacos , Lipólisis/efectos de los fármacos , Propionatos/administración & dosificación , Acetil-CoA Carboxilasa/genética , Acetil-CoA Carboxilasa/metabolismo , Tejido Adiposo/metabolismo , Alimentación Animal , Animales , Carnitina O-Palmitoiltransferasa/genética , Carnitina O-Palmitoiltransferasa/metabolismo , Castración , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Acido Graso Sintasa Tipo I/genética , Acido Graso Sintasa Tipo I/metabolismo , Insulina/sangre , Leptina/sangre , Lipogénesis/genética , Lipólisis/genética , Masculino , PPAR delta/genética , PPAR delta/metabolismo , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/genética , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/metabolismo , Porcinos , Triglicéridos/sangre , Destete , Receptor fas/genética , Receptor fas/metabolismo
19.
Poult Sci ; 96(11): 4053-4060, 2017 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-29050428

RESUMEN

Increasing antibiotic resistance is a major public health concern. Fluoroquinolones are used to treat and prevent poultry diseases worldwide. Fluoroquinolone resistance rates are high in their countries of use. The aim of this study was to evaluate the effect of an acids-based feed additive, as well as fluoroquinolone antibiotics, on the prevalence of antibiotic-resistant E. coli. A total of 480 broiler chickens (Ross 308) were randomly assigned to 3 treatments: a control group receiving a basal diet; a group receiving a feed additive (FA) based on formic acid, acetic acid and propionic acid; and an antibiotic enrofloxacin (AB) group given the same diet, but supplemented with enrofloxacin in water. A pooled fecal sample of one-day-old chicks was collected upon arrival at the experimental farm. On d 17 and d 38 of the trial, cecal samples from each of the 8 pens were taken, and the count of E. coli and antibiotic-resistant E. coli was determined.The results of the present study show a high prevalence of antibiotic-resistant E. coli in one-day-old chicks. Supplementation of the diet with FA and treatment of broilers with AB did not have a significant influence on the total number of E. coli in the cecal content on d 17 and d 38 of the trial. Supplementation with FA contributed to better growth performance and to a significant decrease (P ≤ 0.05) in E. coli resistant to ampicillin and tetracycline compared to the control and AB groups, as well as to a decrease (P ≤ 0.05) in sulfamethoxazole and ciprofloxacin-resistant E. coli compared to the AB group. Treatment with AB increased (P ≤ 0.05) the average daily weight compared to the control group and increased (P ≤ 0.05) the number of E. coli resistant to ciprofloxacin, streptomycin, sulfamethoxazole and tetracycline; it also decreased (P ≤ 0.05) the number of E. coli resistant to cefotaxime and extended spectrum beta-lactamase- (ESBL-) producing E. coli in the ceca of broilers.


Asunto(s)
Antibacterianos/farmacología , Pollos , Suplementos Dietéticos/análisis , Farmacorresistencia Bacteriana , Infecciones por Escherichia coli/veterinaria , Fluoroquinolonas/farmacología , Enfermedades de las Aves de Corral/epidemiología , Ácido Acético/administración & dosificación , Ácido Acético/metabolismo , Alimentación Animal/análisis , Animales , Ciego/microbiología , Dieta/veterinaria , Enrofloxacina , Escherichia coli/efectos de los fármacos , Infecciones por Escherichia coli/tratamiento farmacológico , Infecciones por Escherichia coli/epidemiología , Infecciones por Escherichia coli/microbiología , Femenino , Formiatos/administración & dosificación , Formiatos/metabolismo , Masculino , Enfermedades de las Aves de Corral/tratamiento farmacológico , Enfermedades de las Aves de Corral/microbiología , Prevalencia , Propionatos/administración & dosificación , Propionatos/metabolismo , Distribución Aleatoria
20.
Fish Shellfish Immunol ; 60: 65-71, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27840173

RESUMEN

This experiment was conducted to study the effect of various levels of ACV® and Propionic acid (PA) on expression of immune related genes and growth performance in white shrimp (Litopenaeus vannamei). Three hundred and seventy-five shrimps with an average initial weight of 10.2 ± 0.04 g were collected and acclimatized for two weeks. Five experimental diets including control diet, 0.5% PA diet and 1%, 2% and 4% ACV® diets were applied to feed the shrimps. They were fed 4 times a day with 2.5% of body weight. After 60 days of culture, shrimps fed with ACV® and PA diets showed no significant difference in growth performance. Expression of prophenoloxidase (proPo), lysozyme (Lys), penaeidin-3a (Pen-3a) and Crustin (Cru) genes were determined from hepatopancreas, using the real-time PCR after 15, 30 and 60 days. Expression of Lys and proPo genes was significantly up regulated in shrimps fed with ACV® and PA diets compared to the control group after 30 and 60 days of treatment. After 15 days, Pen-3a gene expression was significantly higher in PA group compared to the control group. Also, shrimps fed with 1% and 4% ACV® and PA diets showed significantly increased expression of Pen-3a after 30 days. In contrast, expression of Cru was significantly down regulated in response to ACV® diets, but, Cru expression in treated shrimps with PA diet was greater than the control group after 30 and 60 days. Overall, the results provided evidence that ACV® could be used as a natural immunostimulant for shrimps in order to adjust and enhance expression of the immune related genes.


Asunto(s)
Ácido Acético/inmunología , Suplementos Dietéticos , Regulación de la Expresión Génica , Inmunidad Innata , Malus/química , Penaeidae , Propionatos/inmunología , Ácido Acético/administración & dosificación , Alimentación Animal/análisis , Animales , Dieta , Penaeidae/genética , Penaeidae/crecimiento & desarrollo , Penaeidae/inmunología , Propionatos/administración & dosificación , Distribución Aleatoria
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA